skip navigation
NIH Record  
Vol. LXV, No. 25
  December 6, 2013
2013 Nobelist Levitt Speaks at NIH
NICHD, Partner Agencies Implement Successful Baby Health Campaign
Veterans Day Celebrated at NIH
NLM MedlinePlus Marks 15th Anniversary
Casadevall To Speak on Origins of Microbial Virulence
Mider Lecture Features NIAID’s Holland, Dec. 11
Duke’s Califf Gives Straus Lecture, Dec. 16
NIH-Gallaudet Partnership Wraps Up Busy Fall Season
printer friendly version
The Joy of Science
Research Festival Celebrates 60th Anniversary of Double Helix, Clinical Center

NIA’s Dr. Luigi Ferrucci at Research Festival 2013
NIA’s Dr. Luigi Ferrucci at Research Festival 2013

Every year, the NIH Research Festival highlights the work of the intramural community. It’s an opportunity to learn about the amazing research taking place in NIH laboratories. And it’s an occasion for NIH scientists, from the apprentice to the veteran, to mingle and network.

At the 27th NIH Research Festival, held Nov. 6-8, “The joy of doing science was palpable,” said festival co-chair Dr. Luigi Ferrucci, scientific director of NIA.

This year’s festival celebrated two milestones: publication of the Watson & Crick paper that first described the double helix structure of DNA and the 60th anniversary of the Clinical Center. To honor these achievements, much of the festival focused on advances in molecular medicine.

Great Expectations
Colloca Re-Evaluates the Placebo Effect

Dr. Luana Colloca
Dr. Luana Colloca
The placebo effect is surrendering its secrets.

“The placebo effect is a very complex psycho-neurobiological phenomenon wherein humans or animals experience an enhanced benefit via positive expectations,” said Dr. Luana Colloca in her recent lecture at Lipsett Amphitheater.

A research fellow with NCCAM and NIMH, Colloca presented the talk, “Re-evaluating the Placebo Effect in Medicine,” as part of the Grand Rounds for Clinical Fellows lecture series.

“There are many contexts where we are talking about placebo and placebo effects,” Colloca continued. “Randomized clinical trials, experimental research settings and clinical settings or encounters.”